Borrelia Miyamotoi: An Emerging Tick-Borne Pathogen

B. miyamotoi was detected in Ixodes scapularis ticks in Connecticut in 2001 [2], but the first human case in the United States was not reported until 2013 [3]. Unlike with Lyme disease, patients in the United States with B. miyamotoi infections typically do not have skin lesions and instead present with a non-specific febrile illness, potentially associated with leukopenia, thrombocytopenia and elevated liver function tests [4]. Highly immunocompromised patients may develop chronic meningitis [3].
Source: The American Journal of Medicine - Category: General Medicine Authors: Source Type: research